Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trail

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.
Cancer Immunology Research|March 23, 2022
A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor RegressionNicolò Rigamonti, Niina Veitonmäki, Clara Domke, et al.
The Bone & Joint Journal|December 3, 2016
Medium-term outcomes of the Universal-2 total wrist arthroplasty in patients with rheumatoid arthritisR Badge, K Kailash, D R Dickson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 1998
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesisW R Ji, F J Castellino, Y Chang, et al.
Cancer Research|December 4, 2001
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291J G Naglich, M Jure-Kunkel, E Gupta, et al.
Cancer Research|January 20, 2011
Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growthJin Gao, Jon W Chesebrough, Susan A Cartlidge, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2006
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsYong S Chang, Jalila Adnane, Pamela A Trail, et al.
Leukemia|January 6, 2007
Antitumor activity of sorafenib in FLT3-driven leukemic cellsD Auclair, D Miller, V Yatsula, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.
Cancer Immunology Research|March 23, 2022
A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor RegressionNicolò Rigamonti, Niina Veitonmäki, Clara Domke, et al.
The Bone & Joint Journal|December 3, 2016
Medium-term outcomes of the Universal-2 total wrist arthroplasty in patients with rheumatoid arthritisR Badge, K Kailash, D R Dickson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 1998
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesisW R Ji, F J Castellino, Y Chang, et al.
Cancer Research|December 4, 2001
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291J G Naglich, M Jure-Kunkel, E Gupta, et al.
Cancer Research|January 20, 2011
Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growthJin Gao, Jon W Chesebrough, Susan A Cartlidge, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2006
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsYong S Chang, Jalila Adnane, Pamela A Trail, et al.
Leukemia|January 6, 2007
Antitumor activity of sorafenib in FLT3-driven leukemic cellsD Auclair, D Miller, V Yatsula, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Pageof 16